JP2007508309A - Coated metal pyrithione particles for treating microorganisms - Google Patents

Coated metal pyrithione particles for treating microorganisms Download PDF

Info

Publication number
JP2007508309A
JP2007508309A JP2006534294A JP2006534294A JP2007508309A JP 2007508309 A JP2007508309 A JP 2007508309A JP 2006534294 A JP2006534294 A JP 2006534294A JP 2006534294 A JP2006534294 A JP 2006534294A JP 2007508309 A JP2007508309 A JP 2007508309A
Authority
JP
Japan
Prior art keywords
particles
pyrithione
coated
composition
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006534294A
Other languages
Japanese (ja)
Other versions
JP4664919B2 (en
Inventor
レイ、ドゥチン
ポルソン、ジョージ
シッコグナニ、ダイアナ、ティー.
ディニコラ、ケビン、エヌ.
シャルヴォイ、リチャード、ビー.
ロバーツ、キャサリン、ピー.
プント、ルイス、エル.
シュワルツ、ジェームズ、ロバート
コーフマン、デーヴィッド、ジョゼフ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of JP2007508309A publication Critical patent/JP2007508309A/en
Application granted granted Critical
Publication of JP4664919B2 publication Critical patent/JP4664919B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11Encapsulated compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4933Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

A composition comprising coated particles of a salt of pyrithione selected from the group consisting of monovalent and polyvalent pyrithione salts, and combinations thereof, partially or fully coated with a lipophilic agent. The composition is characterized by enhanced anti-fungal and anti-dandruff efficacy in shampoos. Also disclosed is a personal care composition, preferably a shampoo, containing a topical carrier and coated particles of a salt of pyrithione selected from the group consisting of monovalent and polyvalent pyrithione salts, and combinations thereof, partially or fully coated with a lipophilic agent.

Description

本発明は、被覆されたピリチオン塩粒子で、その被覆によりピリチオン部分の効能が改良され、それによりその組成物により与えられる抗菌効能の持続時間を増大した被覆ピリチオン塩粒子に関する。前記組成物は、人のケアー組成物、特にシャンプー中に配合すると、抗菌、特に抗真菌効能を与えるのに有用である。   The present invention relates to coated pyrithione salt particles, wherein the coating improves the efficacy of the pyrithione moiety, thereby increasing the duration of the antimicrobial efficacy provided by the composition. The composition is useful for providing antibacterial, especially antifungal efficacy, when formulated in human care compositions, particularly shampoos.

シャンプーでは、被覆の親油性が、頭皮、特に、ふけを生ずることが知られている親油性酵母のような親油性微生物を含む頭皮の部位への標的送達を達成し易くする。本発明の被覆粒子を含むシャンプーは、被覆されていないピリチオン塩粒子を含むシャンプーと比較して、増大した抗真菌効能を示す。   In shampoos, the lipophilicity of the coating makes it easier to achieve targeted delivery to the scalp, particularly to sites of the scalp that contain lipophilic microorganisms such as lipophilic yeasts known to cause dandruff. Shampoos comprising the coated particles of the present invention exhibit increased antifungal efficacy compared to shampoos comprising uncoated pyrithione salt particles.

亜鉛及び銅ピリチオンのような金属ピリチオンは、効果的な抗菌剤としてよく知られている。亜鉛ピリチオンは、シャンプーのふけ防止及び抗真菌成分として活性であることがよく知られており、広く用いられている。   Metal pyrithiones such as zinc and copper pyrithione are well known as effective antimicrobial agents. Zinc pyrithione is well known to be active as a shampoo anti-dandruff and antifungal component and is widely used.

PTC特許出願WO 03/007900には、ふけを処理するため皮膚及び頭皮中の脂質のレベルを増大するように、亜鉛ピリチオンと共にセラミドのような親油性剤を使用することが記載されている。しかし、シャンプー配合物中に脂質とピリチオン塩との混合物を使用することは、頭皮の或る場所に脂質を優先的到達させ、別の場所にピリチオン塩が送達されたりすることがある欠点を有する。   PTC patent application WO 03/007900 describes the use of lipophilic agents such as ceramide with zinc pyrithione to increase the level of lipids in the skin and scalp to treat dandruff. However, the use of a mixture of lipid and pyrithione salt in a shampoo formulation has the disadvantage of preferentially reaching the lipid to one location on the scalp and delivering the pyrithione salt to another location. .

本発明は、ピリチオン粒子の上に脂質被覆を用いて、単一のパッケージとして脂質及びピリチオンを標的送達し易くすることにより、前記欠点に対処するものである。   The present invention addresses the above disadvantages by using a lipid coating on the pyrithione particles to facilitate targeted delivery of the lipid and pyrithione as a single package.

一つの態様として、本発明は、部分的又は完全に親油性剤で被覆された、一価及び多価ピリチオン塩、及びそれらの組合せからなる群から選択されたピリチオン塩の被覆された粒子を含む組成物に関する。この組成物は、シャンプーに増大した抗真菌及びふけ防止効能を与える。   In one embodiment, the present invention comprises coated particles of pyrithione salts selected from the group consisting of monovalent and polyvalent pyrithione salts, and combinations thereof, partially or fully coated with a lipophilic agent. Relates to the composition. This composition provides shampoos with increased antifungal and antidandruff efficacy.

別の態様として、本発明は、局所的なキャリヤー、及び部分的又は完全に親油性剤で被覆された、一価及び多価ピリチオン塩、及びそれらの組合せからなる群から選択されたピリチオン塩の被覆された粒子を含む人のケアー組成物、好ましくはシャンプーに関する。   In another aspect, the invention provides a pyrithione salt selected from the group consisting of topical carriers and mono- and polyvalent pyrithione salts, and combinations thereof, partially or fully coated with a lipophilic agent. It relates to a human care composition comprising coated particles, preferably a shampoo.

更に別の態様として、本発明は、固体亜鉛ピリチオン粒子で、その外側表面上に固体パーム油被覆を有する固体亜鉛ピリチオン粒子の水性分散物を製造する方法において、
(a) 固体亜鉛ピリチオン粒子の水性分散物を、約50℃〜約80℃の上昇させた温度へ加熱し、高温水性分散物を与える工程、
(b) 固体パーム油を、約50℃〜約80℃の上昇させた温度へ加熱し、液体パーム油を与え、そして
(c) 前記液体パーム油と、前記高温水性分散物とを混合して混合物を与え、前記混合物を冷却して前記固体パーム油の被覆を有する固体亜鉛ピリチオン粒子の水性分散物を与える工程、
を含む製造方法に関する。得られた分散物は、その分散物の全重量に基づき、約40%〜約50%の量で、適切に被覆された亜鉛ピリチオン粒子を含む。
In yet another aspect, the present invention provides a method for producing an aqueous dispersion of solid zinc pyrithione particles having solid palm oil coating on its outer surface with solid zinc pyrithione particles.
(A) heating an aqueous dispersion of solid zinc pyrithione particles to an elevated temperature of about 50 ° C. to about 80 ° C. to provide a high temperature aqueous dispersion;
(B) heating solid palm oil to an elevated temperature of about 50 ° C. to about 80 ° C. to provide liquid palm oil; and (c) mixing the liquid palm oil with the high temperature aqueous dispersion. Providing a mixture and cooling the mixture to provide an aqueous dispersion of solid zinc pyrithione particles having the solid palm oil coating;
It relates to the manufacturing method containing. The resulting dispersion contains suitably coated zinc pyrithione particles in an amount of about 40% to about 50%, based on the total weight of the dispersion.

更に別の態様として、本発明は、分散物の全重量に基づき、水、及び約25重量%〜約50重量%の固体ピリチオン塩粒子を含む水性抗菌分散濃厚物に関する。固体ピリチオン塩粒子は、その外側表面に親油性被覆を有する被覆された粒子である。それら被覆粒子は、比較コルネオファンジメトリー(corneofungimetry)生物検定試験で、前記ピリチオン塩の被覆されていない粒子の分散物の前記生物検定試験での抗菌効能と比較して、少なくとも25%の抗菌効能改良を示す。別の態様は、人のケアー組成物で、その人のケアー組成物の全重量に基づき、局所的キャリヤー及び約0.5%〜約5%の前記濃厚物を含む人のケアー組成物に関する。人のケアー組成物は、比較コルネオファンジメトリー生物検定試験で、前記ピリチオン塩の被覆されていない粒子の分散物を同じ量で含む人のケアー組成物の前記生物検定試験での抗菌効能と比較して、少なくとも15%の抗菌効能改良を示す。   In yet another aspect, the present invention relates to an aqueous antimicrobial dispersion concentrate comprising water and about 25 wt% to about 50 wt% solid pyrithione salt particles, based on the total weight of the dispersion. Solid pyrithione salt particles are coated particles having a lipophilic coating on their outer surface. The coated particles have at least 25% antimicrobial efficacy in a comparative corneofungimetry bioassay test compared to the antimicrobial efficacy in the bioassay test of the dispersion of the uncoated particles of pyrithione salt. Indicates an improvement. Another aspect relates to a human care composition comprising a topical carrier and from about 0.5% to about 5% of the concentrate, based on the total weight of the person's care composition. The human care composition is compared with the antimicrobial efficacy of the human care composition containing the same amount of the uncoated particles of pyrithione salt in the comparative corneophanemetry bioassay test. An antibacterial efficacy improvement of at least 15%.

これら及び他の態様は、本発明についての次の詳細な記述を読むことにより明らかになるであろう。   These and other aspects will become apparent upon reading the following detailed description of the invention.

本発明の詳細な記述
今回、親油性脂肪油被覆を含む被覆されたピリチオン粒子が、頭皮の希望の親油性部位にピリチオンを送達するのに効果的な伝達手段を与えることが思いがけなく発見された。これらの部位では、ふけを生ずることが知られている親油性Malassezia sp イーストのような親油性微生物が見出される傾向がある。これらの部位を標的とする送達は、これらの被覆ピリチオン粒子を含有するシャンプーの抗真菌及びふけ防止効能を、被覆されていないピリチオン粒子を含むシャンプーと比較して増大する。
Detailed Description of the Invention It has now been unexpectedly discovered that coated pyrithione particles comprising a lipophilic fatty oil coating provide an effective vehicle for delivering pyrithione to the desired lipophilic site of the scalp. At these sites there is a tendency to find lipophilic microorganisms such as lipophilic Malassezia sp yeast that are known to cause dandruff. Delivery targeted to these sites increases the antifungal and anti-dandruff efficacy of shampoos containing these coated pyrithione particles compared to shampoos containing uncoated pyrithione particles.

本発明で用いられるピリチオン粒子は、亜鉛、銅、銀、ジルコニウムの塩、及びそれらの組合せからなる群から選択されるのが好ましい。一層好ましいピリチオン塩は、亜鉛及び銅の塩から選択され、最も好ましくは亜鉛塩である。亜鉛塩は、粒状分散物、スラリー、又は粉末の形で適切に用いられる。亜鉛ピリチオンは、例えば、板状子、棒状、針状、ブロック状、球状、及び無定形、規則的又は不規則な形をした粒子のような結晶形態を含むどのような粒子形態で用いてもよい。亜鉛ピリチオン粒子の平均粒子直径(最大寸法)が、例えばホリバ(Horiba)LA−910レーザー散乱粒径分布分析器を用いて決定して、典型的には、約0.1〜約50μmであり、好ましくは約0.1μm〜約10μm、一層好ましくは約0.1μm〜約5μmである。   The pyrithione particles used in the present invention are preferably selected from the group consisting of zinc, copper, silver, zirconium salts, and combinations thereof. More preferred pyrithione salts are selected from zinc and copper salts, most preferably zinc salts. Zinc salts are suitably used in the form of granular dispersions, slurries or powders. Zinc pyrithione may be used in any particle form, including, for example, crystalline forms such as platelets, rods, needles, blocks, spheres, and amorphous, regular or irregular shaped particles. . The average particle diameter (maximum dimension) of the zinc pyrithione particles is typically about 0.1 to about 50 μm, as determined using, for example, a Horiba LA-910 laser scattering particle size distribution analyzer, The thickness is preferably about 0.1 μm to about 10 μm, more preferably about 0.1 μm to about 5 μm.

本発明の被覆粒子上の親油性被覆は、室温で固体又は液体である合成又は天然の脂肪油を含む。従って、ここで用いられる用語「親油性剤」とは、油及びワックスの両方を包含するものとする。脂肪油は、約150〜約1500の範囲内の数平均分子量、及び8〜22の範囲内の炭素数を有する脂肪酸又は脂肪酸エステル、又はそれらの混合物を含む。脂肪酸エステルは、モノ−、ジ−、又はトリ−グリセリド、又はそれらの混合物を含むことができる。好ましい被覆材料は、パーム油である。   The lipophilic coating on the coated particles of the present invention comprises a synthetic or natural fatty oil that is solid or liquid at room temperature. Thus, as used herein, the term “lipophilic agent” is intended to encompass both oils and waxes. The fatty oil comprises a fatty acid or fatty acid ester having a number average molecular weight in the range of about 150 to about 1500 and a carbon number in the range of 8 to 22, or mixtures thereof. Fatty acid esters can include mono-, di-, or tri-glycerides, or mixtures thereof. A preferred coating material is palm oil.

親油性被覆成分が占める割合は、被覆ピリチオン粒子の全重量に基づき、好ましくは0.01重量%より大きく、好ましくは1重量%より大きく、一層好ましくは3重量%より大きい。典型的には、被覆粒子中の親油性剤含有量は、約3〜15%の範囲にある。1重量%の亜鉛ピリチオンを含有するシャンプーでは、親油性被覆薬剤の量は、シャンプーの重量に基づき、一般に約0.001重量%〜約0.15重量%、好ましくは約0.01重量%〜約0.15重量%、一層好ましくは約0.03重量%〜約0.15重量%である。   The proportion occupied by the lipophilic coating component is preferably greater than 0.01% by weight, preferably greater than 1% by weight, more preferably greater than 3% by weight, based on the total weight of the coated pyrithione particles. Typically, the lipophilic agent content in the coated particles is in the range of about 3-15%. For shampoos containing 1% by weight zinc pyrithione, the amount of lipophilic coating agent is generally from about 0.001% to about 0.15% by weight, preferably from about 0.01% to about 0.1%, based on the weight of the shampoo. About 0.15 wt%, more preferably about 0.03 wt% to about 0.15 wt%.

適当な脂肪酸及び脂肪酸エステルには、炭化水素油、ワックス、ジ−、及びトリ−グリセリド油が含まれ、例えば、ワセリン、鉱油ワックス、水素化及び非水素化ポリアルケン、水素化油、パラフィン、合成パラフィン、ポリエチレン及びポリブテンパーム油、ひまし油、大豆油、誘導体化大豆油、例えば、ひまわり油、綿実油、コーン油、くるみ油、落花生油、胡麻油、植物油、植物油誘導体、ココナッツ油、ココナッツ油誘導体が含まれる。   Suitable fatty acids and fatty acid esters include hydrocarbon oils, waxes, di- and triglyceride oils, such as petrolatum, mineral oil wax, hydrogenated and non-hydrogenated polyalkenes, hydrogenated oils, paraffins, synthetic paraffins. Polyethylene and polybutene palm oil, castor oil, soybean oil, derivatized soybean oil, such as sunflower oil, cottonseed oil, corn oil, walnut oil, peanut oil, sesame oil, vegetable oil, vegetable oil derivative, coconut oil, coconut oil derivative.

脂肪酸/脂肪酸エステルは、天然産又はそれらの誘導体にすることができる。被覆の炭素鎖の長さは、一般にC8〜C22であり、それらの混合物が含まれる。脂肪酸は、飽和及び不飽和、線状及び分岐鎖脂肪酸にすることができる。それらは、脂肪酸及びそれらからの誘導体の化学的及び物理的性質に基づき選択される。   The fatty acid / fatty acid ester can be naturally occurring or derivatives thereof. The carbon chain length of the coating is generally C8-C22 and includes mixtures thereof. The fatty acids can be saturated and unsaturated, linear and branched chain fatty acids. They are selected based on the chemical and physical properties of the fatty acids and their derivatives.

脂肪酸及びそれらの誘導体の適当な天然及び合成源には、動物及び植物起源のもの、例えば、ラノリン油、魚油、動物油、ココナッツ油、パーム油、バター脂肪、大豆油、ひまわり油、綿実油、コーン油、及びそれらの混合物が含まれる。好ましい脂肪酸源は、パーム油、部分的及び完全に水素化した脂肪油、脂肪酸、例えば、水素化大豆油、パーム油、パームカーネル油、魚油、ポリオール脂肪酸エステルである。   Suitable natural and synthetic sources of fatty acids and their derivatives include those of animal and plant origin, such as lanolin oil, fish oil, animal oil, coconut oil, palm oil, butterfat, soybean oil, sunflower oil, cottonseed oil, corn oil And mixtures thereof. Preferred fatty acid sources are palm oil, partially and fully hydrogenated fatty oils, fatty acids such as hydrogenated soybean oil, palm oil, palm kernel oil, fish oil, polyol fatty acid esters.

一つの別の仕方として、親油性被覆剤は室温で固体であり、上昇させた温度で液体になり、冷却してフィルムを形成する。固体被覆材料は、約40〜100℃で液体になり、次に冷却する間にフィルムを形成することができるのが望ましい。別法として、親油性被覆剤は、適当に溶媒に溶解し、それを乾燥させるとフィルムを形成する。例として被覆剤を有機溶媒、例えば、メタノール及びエタノールのようなアルキルアルコール、アセトン、エーテル、ハロゲン化炭化水素、及び芳香族溶媒の中に適当に溶解し、次にその溶媒を蒸発させる間にフィルムを形成する。   As an alternative, the lipophilic coating is solid at room temperature, becomes liquid at elevated temperatures, and cools to form a film. Desirably, the solid coating material becomes liquid at about 40-100 ° C. and can form a film during subsequent cooling. Alternatively, the lipophilic coating is suitably dissolved in a solvent and dried to form a film. By way of example, the coating is suitably dissolved in an organic solvent, for example an alkyl alcohol such as methanol and ethanol, acetone, ether, halogenated hydrocarbons, and aromatic solvents, and then the film is evaporated while the solvent is evaporated. Form.

本発明で水中での粒子被覆には、被覆材料が液体状態になっているか、又は溶液状態になっている条件下で、被覆材料を存在させたスラリー又は懸濁状態の金属ピリチオン又はピリチオン粒子の多価塩の被覆が含まれる。被覆した粒子の大きさ、形、及び厚さは、スラリー又は懸濁物中の元の粒子の大きさ及び形、温度、及び用いた被覆材料の量に依存する。この方法は、液体状態の(望ましくは約90℃より低い融点温度で)被覆材料を、その被覆材料が液体状態になっている温度でスラリー又は懸濁物中へ適当な速度で撹拌しながら添加し、次に金属ピリチオンスラリーと被覆成分との混合物、又は被覆材料の混合物を冷却するか、又は用いた被覆材料の最も高い融点温度に加熱し、次に冷却するものとして簡単に記述することができる。   In the present invention, for particle coating in water, a slurry of a coating or a suspended metal pyrithione or pyrithione particle under the condition that the coating material is in a liquid state or a solution state. A polyvalent salt coating is included. The size, shape, and thickness of the coated particles depend on the size and shape of the original particles in the slurry or suspension, the temperature, and the amount of coating material used. This method involves adding a coating material in a liquid state (preferably at a melting temperature below about 90 ° C.) to the slurry or suspension at a temperature at which the coating material is in a liquid state with stirring at an appropriate rate. And then briefly described as a mixture of the metal pyrithione slurry and coating component, or a mixture of coating materials, or heated to the highest melting temperature of the coating material used and then cooled. it can.

有機溶媒中での粒子被覆は、金属ピリチオン又はピリチオン粉末の多価塩を、室温以上の温度で有機溶媒に入れた被覆材料(一種又は多種)の溶液へ添加し、次に撹拌しながら溶媒を蒸発させることを含んでいる。被覆された粒子の大きさ、形、及び厚さは、元の粒子の大きさ、金属ピリチオンの形、及び被覆材料の量及び性質に依存する。   Particle coating in an organic solvent involves adding a metal pyrithione or polyvalent salt of pyrithione powder to a solution of the coating material (one or many) in an organic solvent at a temperature above room temperature, and then stirring the solvent while stirring. Includes evaporation. The size, shape, and thickness of the coated particles depend on the original particle size, the shape of the metal pyrithione, and the amount and nature of the coating material.

重合体被覆材料の融点以上の温度でピリチオンを被覆するのに粉末被覆も適切に用いることができる。液体被覆材料は、冷却する間に、粒子上にフィルム又は被覆層を形成する。被覆した量の大きさ、形、及び被覆の厚さは、金属ピリチオン粒子の元の大きさ及び形、及び用いた被覆材料の量及び性質に依存する。この方法は、低い(好ましくは約90℃より低い)融点を有する材料で粒子を被覆するのに特に適している。   A powder coating can also be suitably used to coat pyrithione at temperatures above the melting point of the polymer coating material. The liquid coating material forms a film or coating layer on the particles while cooling. The size, shape, and coating thickness of the amount coated depends on the original size and shape of the metal pyrithione particles and the amount and nature of the coating material used. This method is particularly suitable for coating particles with materials having a low (preferably less than about 90 ° C.) melting point.

本発明の被覆ピリチオン粒子は、局所的キャリヤーを含む人のケアー組成物に用いるのに適している。局所的キャリヤーは、形成される組成物の種類により、慣用的人のケアーキャリヤーの広い範囲から選択するのが適切である。相容性キャリヤーを適切に選択することにより、ヘヤーリンスのような日常の皮膚又は毛髪用製品、ヘヤーローション、ヘヤースプレー、ヘヤートニック、コンディショニング・トリートメント、及びドレッシングのような日常の毛髪手入れ用品等の形態で、本発明の抗菌組成物を調製できるようにすることが考えられている。   The coated pyrithione particles of the present invention are suitable for use in human care compositions containing a topical carrier. The topical carrier is suitably selected from a wide range of conventional human care carriers, depending on the type of composition being formed. By appropriately selecting a compatible carrier, forms of daily skin or hair products such as hair rinses, daily hair care products such as hair lotions, hair sprays, hair tonics, conditioning treatments, and dressings, etc. Thus, it is considered that the antibacterial composition of the present invention can be prepared.

液体ヘヤー組成物中の局所的キャリヤーは、水、一般的有機溶媒、又はそれらの混合物にすることができる。適当な一般的有機溶媒は、エタノール、プロパノール、イソプロパノール、グリセリンのようなC2−C3アルキルアルコールである。脂肪アルコール及びエステルのような他の溶媒も用いることができる。   The topical carrier in the liquid hair composition can be water, a common organic solvent, or a mixture thereof. Suitable common organic solvents are C2-C3 alkyl alcohols such as ethanol, propanol, isopropanol, glycerin. Other solvents such as fatty alcohols and esters can also be used.

本発明の抗菌組成物は、組成物の重量で、約40%〜約92%、好ましくは約50%〜約85%、一層好ましくは約60%〜約80%の水を含む水性系でもよい。   The antimicrobial composition of the present invention may be an aqueous system comprising about 40% to about 92%, preferably about 50% to about 85%, more preferably about 60% to about 80% water by weight of the composition. .

本発明の組成物がふけ防止シャンプーである場合、組成物のpHは、一般に約2〜約10、好ましくは約3〜約9、一層好ましくは約4〜約8、最も好ましくは約5.5〜約7.5の範囲にある。   When the composition of the present invention is an anti-dandruff shampoo, the pH of the composition is generally about 2 to about 10, preferably about 3 to about 9, more preferably about 4 to about 8, and most preferably about 5.5. Is in the range of ~ 7.5.

次の例は、本発明を例示するためであり、その範囲を何ら限定するものではない。全ての被覆粒子は、ESCA、SEM、及び粒径分布分析器により特徴付けられ、被覆粒径分布中の亜鉛ピリチオンの含有量は、標準滴定法を用いて決定された。   The following examples are intended to illustrate the present invention and are not intended to limit its scope in any way. All coated particles were characterized by ESCA, SEM, and particle size distribution analyzer, and the content of zinc pyrithione in the coated particle size distribution was determined using standard titration methods.

例1
約3.4μのメジアン粒径を有する亜鉛ピリチオン粉末(約200g)を、小さな粒化機中へ入れた。パーム油(約24g)を、ホットプレートの上で溶融し、70℃に維持した加熱供給物容器中に入れた。二つの流体ノズルを加熱追跡し、75℃に維持した。粒化機を始動させ、溶融被覆材料を撹拌粉末中へ噴霧した。
Example 1
Zinc pyrithione powder (about 200 g) having a median particle size of about 3.4μ was placed in a small granulator. Palm oil (about 24 g) was melted on a hot plate and placed in a heated feed container maintained at 70 ° C. The two fluid nozzles were heated and maintained at 75 ° C. The granulator was started and the molten coating material was sprayed into the stirred powder.

被覆粒子は次の特徴を持っていた:
亜鉛ピリチオン分析値:85.8%
粒径〔ホリバ(Horriba)LA−910〕:メジアン(D50):7.44μm;比表面積:2分超音波処理後、17647cm/cm
The coated particles had the following characteristics:
Analysis value of zinc pyrithione: 85.8%
Particle size [Horiba (Horriba) LA-910]: median (D 50): 7.44μm; specific surface area: after 2 min sonication, 17647cm 2 / cm 3.

原子濃度のESCA分析及びZn及びS信号の減衰から誘導された被覆厚さは、被覆の存在が35Åであることを示していた。
被覆粒子のSEM像は、粒子が目で見て被覆されており、クラスターの特徴を有することを示していた。
The coating thickness derived from the ESCA analysis of the atomic concentration and the decay of the Zn and S signals showed that the presence of the coating was 35 mm.
The SEM image of the coated particles showed that the particles were visually coated and had cluster characteristics.

比較例A:
〜65℃のD.I.水150ml中に210.0gの48.0%亜鉛ピリチオン(メジアン粒径0.47μm)を入れた撹拌懸濁物に、60〜65℃のステアリルジメチコン4.1gからなる熱い液体油をゆっくり添加した。この温度で10分間500rpmで撹拌した後、分散物を、300rpmの撹拌速度で徐々に室温へ冷却した。
被覆粒子は、次の特徴を持っていた:
亜鉛ピリチオン分析値:32.0%
粒径(ホリバLA−910):メジアン(D50):0.478μm;平均:0.507μm;比表面積:2分超音波処理後、136981cm/cm
Comparative Example A:
D. of ~ 65 ° C. I. To a stirred suspension of 210.0 g of 48.0% zinc pyrithione (median particle size 0.47 μm) in 150 ml of water was slowly added hot liquid oil consisting of 4.1 g of stearyl dimethicone at 60-65 ° C. . After stirring at 500 rpm for 10 minutes at this temperature, the dispersion was gradually cooled to room temperature with a stirring speed of 300 rpm.
The coated particles had the following characteristics:
Analysis value of zinc pyrithione: 32.0%
Particle size (Horiba LA-910): Median (D 50 ): 0.478 μm; Average: 0.507 μm; Specific surface area: 136811 cm 2 / cm 3 after sonication for 2 minutes.

原子濃度のESCA分析及びZn及びS信号の減衰から誘導された被覆厚さは、表1に示したように、被覆の存在が15Åであることを示していた。被覆粒子のSEM像は、粒子が薄く被覆されていることを示していた。亜鉛ピリチオン粒子(0.1〜1μm、ブロック及び板状子の混合物)は、幾らかの散乱した被覆パッチを有し明確な輪郭をもち、粒子の縁は見かけ上軟化していた。微細亜鉛ピリチオン粒子について見られたように、真っすぐ又は角度のある特徴よりもむしろ湾曲した特徴を有するこれらの被覆に関連した特徴は、元の微細粒子の一部であり、ESCAで見られたように丁度薄い被覆である可能性がある。   The coating thickness derived from the ESCA analysis of atomic concentration and the decay of the Zn and S signals indicated that the presence of the coating was 15 mm, as shown in Table 1. The SEM image of the coated particles showed that the particles were thinly coated. Zinc pyrithione particles (0.1-1 μm, a mixture of blocks and platelets) had some scattered coated patches, had a well-defined profile, and the edges of the particles were apparently softened. As seen for the fine zinc pyrithione particles, these coating-related features with curved features rather than straight or angular features are part of the original fine particles, as seen with ESCA May be just a thin coating.

被覆粒子は、Malassezia furfurに対する定性的阻止帯(Zone of Inhibition)(ZOI)試験で活性を示し、被覆は寒天を通って亜鉛ピリチオンが移動するのを阻止しなかったことを実証していた。   The coated particles showed activity in a Qualitative Zone of Inhibition (ZOI) test against Malassezia furfur, demonstrating that the coating did not block the migration of zinc pyrithione through the agar.

比較例B〜D:
例1−(I)部の手順に従い、48.0%の亜鉛ピリチオン(メジアン粒径0.47μm)の懸濁物中に入れた亜鉛ピリチオン粒子を、アミノ官能性ポリジメチルシロキサン〔アモジメチコン(Amodimethicon)、ダウ・コーニング2−8566アミノ流体、例B〕、レシチン〔セントロミクス(Centromix)LP250、例C〕、及びビス−PEG−12ジメチコン蜜蝋(シリコニル蜜蝋、例D)を用いてその場で被覆した。これらの被覆した亜鉛ピリチオン粒子の特性データーを、表1に記載する。
Comparative Examples B to D:
EXAMPLE 1 Zinc pyrithione particles placed in a suspension of 48.0% zinc pyrithione (median particle size 0.47 μm) according to the procedure of Example 1- (I) were converted to aminofunctional polydimethylsiloxane [Amodimethicon. ), Dow Corning 2-8566 amino fluid, Example B], lecithin [Centromix LP250, Example C], and bis-PEG-12 dimethicone beeswax (Siliconyl beeswax, Example D). did. The characteristic data of these coated zinc pyrithione particles are listed in Table 1.

Figure 2007508309
Figure 2007508309

最初の性能試験では、例1及び比較例の全てが、Malassezia furfurに対する定性的阻止帯(ZOI)試験で被覆粒子抗菌活性を示し、被覆は亜鉛ピリチオンが移動するのを阻止しなかったことを実証していた。   Initial performance tests demonstrated that Example 1 and all of the comparative examples showed coated particle antimicrobial activity in a qualitative zone of inhibition (ZOI) test against Malassezia furfur and the coating did not block the migration of zinc pyrithione. Was.

一層進んだ試験として、「コルネオファンジメトリー」を用いて、例及び比較例に従って調製した粒子を評価した。この試験は、良好な前臨床スクリーニング法である。なぜなら、それは、自然の環境を一層よく代表する基質上でのMalassezia furfur spの増殖を必要とするからである。皮膚層を採取するのにシアノアクリレートを用い、これらの皮膚表面の剥離物をオリーブオイルで処理し、皮脂に類似させる。調製した皮膚試料を、研究中の活性剤で処理し、問題の微生物を接種し、培養した。この研究では、活性剤は、被覆した亜鉛ピリチオン粒子であり、用いた試験有機体はMalassezia furfurであった。処理の相対的効能を、対照と比較して増殖の阻止を探すことにより決定し、このデーターをコンピューターによる画像解析及び生体染色を用いて収集した。それは、被覆亜鉛ピリチオンがMalassezia furfurに対し、被覆していない材料よりも一層効能が高いことを示している。亜鉛ピリチオンの効能を試験するため、1%水性分散物、及びシャンプー配合物中に1%入れた両方を用いた。下の表3に試験結果を示した配合シャンプーは、次の成分を含んでいた:ステパノール(STEPANOL)AM−V陰イオン性表面活性剤、68.3%;ステパン(STEPAN)SAB−2懸濁剤、5%;ニノール(NINOL)40−CO非イオン性発泡剤、2%;被覆亜鉛ピリチオン粒子、ピリチオン含有量に基づき1%;グリダント(GLYDANT)防腐剤、0.3%;100%にするための残余の脱イオン水;全ての重量%はシャンプーの全重量に基づく。   As a further test, the particles prepared according to the examples and comparative examples were evaluated using “Corneophanimetry”. This test is a good preclinical screening method. This is because it requires the growth of Malassezia furfur sp on a substrate that better represents the natural environment. Cyanoacrylate is used to collect the skin layer, and these skin surface exfoliants are treated with olive oil to resemble sebum. The prepared skin samples were treated with the active agent under study, inoculated with the microorganism in question and cultured. In this study, the activator was coated zinc pyrithione particles and the test organism used was Malassezia furfur. The relative efficacy of the treatment was determined by looking for growth inhibition compared to the control, and this data was collected using computer image analysis and vital staining. It shows that coated zinc pyrithione is more effective against Malassezia furfur than uncoated material. To test the efficacy of zinc pyrithione, both a 1% aqueous dispersion and 1% in a shampoo formulation were used. The formulated shampoo, whose test results are shown in Table 3 below, contained the following ingredients: STEPANOL AM-V anionic surfactant, 68.3%; STEPAN SAB-2 suspension NINOL 40-CO nonionic blowing agent, 2%; coated zinc pyrithione particles, 1% based on pyrithione content; GLYDANT preservative, 0.3%; 100% Residual deionized water for; all weight percentages are based on the total weight of the shampoo.

シアノアクリレート接着剤を用いて20人の健康なボランティアから採取した正常な角膜層(stratum corneum)でコルネオファンジメトリー生物検定を行った。試料をオリーブ油中に浸漬し、殺菌環境中に3日間保存した。オリーブ油を含浸させた角膜層試料を、第二段階で亜鉛ピリチオンの1%分散水又は1%の亜鉛ピリチオンを含有するシャンプー中に浸漬した。「コルネオファンジメトリー」試験による更に別の情報が、「臨床及び実験的皮膚病学」(Clinical and Experimental Dermatology)(1989)、第14巻、第425頁〜第428頁に見られるA.ルランギルワ(Rurangirwa)、C.ペイラルド−フランチモント(Peirard-Franchimont)、及びG.E.ピラルド(Pierard)Cによる「シアノアクリレート皮膚表面剥離物上の真菌培養−抗真菌薬剤を評価するための定量的生物検定」(Culture of fungi on cyanoacrylate skin surface strippings-a quantitative bioassay for evaluating antifungal drugs)と題する技術雑誌論文で入手することができる。   Corneophanometry bioassays were performed on normal stratum corneum taken from 20 healthy volunteers using cyanoacrylate glue. Samples were soaked in olive oil and stored in a sterilized environment for 3 days. The corneal layer sample impregnated with olive oil was immersed in a shampoo containing 1% zinc pyrithione dispersion or 1% zinc pyrithione in the second stage. Further information from the “Corneophanometry” test can be found in “Clinical and Experimental Dermatology” (1989), Vol. 14, pp. 425-428. Rurangirwa, C.I. Peirard-Franchimont, and G.M. E. "Pulture of fungi on cyanoacrylate skin surface strippings-a quantitative bioassay for evaluating antifungal drugs" by Pierard C Available in technical journal papers.

Malassezia furfurを、MLMA〔変性リーミング(Modified Leeming)及びノットマン(Notman)寒天〕媒地で培養した。真菌細胞の懸濁物を生理的食塩水(10〜10細胞/ml)に入れて調製した。これらの懸濁物250μl部分を、角膜層試料上に付着させ、27℃で9日間湿潤状態で培養した。試料を、生体染色として天然赤色を用いて染色し、人間の角膜層上に増殖した生きた真菌を同定した。コンピューターによる画像解析(アナリシス・オリンパス)を用いてmm単位で陽性真菌細胞数を計算した。メジアン及び範囲を決定した。一対の非パラメーター・フリードマン(Friedman)試験を用い、次にダン(Dunn)試験を用いて生成物間比較を行なった。 Malassezia furfur was cultured in MLMA (Modified Leeming and Notman agar) media. A suspension of fungal cells was prepared in physiological saline (10 4 to 10 5 cells / ml). 250 μl portions of these suspensions were deposited on the corneal layer samples and incubated at 27 ° C. for 9 days in a wet state. Samples were stained using natural red as a vital stain to identify live fungi grown on the human corneal layer. The number of positive fungal cells was calculated in mm 2 using computer image analysis (Analysis Olympus). The median and range were determined. A pair of non-parameter Friedman tests were used, followed by a product comparison using the Dunn test.

表2及び3に示したデーターに示されるように、11.7%のパーム油で被覆した試料(例1)は、最もよい抗真菌効能結果(%)を与えることを実証していた。比較として4.0%のステアリルジメチコン(比較例A)は、水分散物及び配合したシャンプーの両方で、被覆していない対照よりも中程度の効能を示したのに対し、7.5%のアミノシリコーンで被覆した試料(比較例B)は、水分散物では幾らか良好な効能の改良を示したが、配合シャンプーでは僅かな改良しか示さなかった。驚いたことに、レシチン(比較例C)及びシリコニル蜜蝋(比較例D)で被覆した試料は、水懸濁物では負の効能改良を示している。   As shown in the data shown in Tables 2 and 3, the sample coated with 11.7% palm oil (Example 1) demonstrated that it gave the best antifungal efficacy results (%). For comparison, 4.0% stearyl dimethicone (Comparative Example A) showed moderate efficacy over both the aqueous dispersion and formulated shampoo over the uncoated control, compared with 7.5% A sample coated with aminosilicone (Comparative Example B) showed some good improvement in efficacy with the aqueous dispersion, but only a slight improvement with the formulated shampoo. Surprisingly, the sample coated with lecithin (Comparative Example C) and siliconyl beeswax (Comparative Example D) shows a negative efficacy improvement in the aqueous suspension.

Figure 2007508309
Figure 2007508309

Figure 2007508309
Figure 2007508309

本発明を、その特別な態様に関連して上に記述してきたが、多くの変化、修正、及び変更を、ここに記載した本発明の概念から離れることなく行うことができることは明らかである。従って、添付の特許請求の範囲の本質及び広い範囲内に入るそのような変化、修正、及び変更は全て包含されるものである。
Although the invention has been described above with reference to specific embodiments thereof, it is apparent that many changes, modifications, and changes can be made without departing from the inventive concepts described herein. Accordingly, it is intended to embrace all such changes, modifications and variations that fall within the essence and broad scope of the appended claims.

Claims (27)

一価及び多価ピリチオン塩、及びそれらの組合せからなる群から選択されたピリチオン塩の、親油性剤で部分的又は完全に被覆された被覆粒子を含む組成物。   A composition comprising coated particles partially or fully coated with a lipophilic agent of a pyrithione salt selected from the group consisting of monovalent and polyvalent pyrithione salts, and combinations thereof. ピリチオン塩が、亜鉛、銅、銀、及びジルコニウム塩、及びそれらの組合せからなる群から選択されている、請求項1に記載の組成物。   The composition of claim 1, wherein the pyrithione salt is selected from the group consisting of zinc, copper, silver, and zirconium salts, and combinations thereof. 親油性剤が、約150〜約1,500の範囲内の数平均分子量を有する天然又は合成脂肪酸、脂肪酸エステル、又はそれらの組合せを含む、請求項1に記載の組成物。   The composition of claim 1, wherein the lipophilic agent comprises natural or synthetic fatty acids, fatty acid esters, or combinations thereof having a number average molecular weight in the range of about 150 to about 1,500. 天然又は合成脂肪酸エステルが、主鎖内に8〜22個の炭素原子を有する、モノ−、ジ−、及びトリ−グリセリド、及びそれらの組合せからなる群から選択されたグリセリドを含む、請求項3に記載の組成物。   The natural or synthetic fatty acid ester comprises a glyceride selected from the group consisting of mono-, di-, and tri-glycerides, and combinations thereof, having 8 to 22 carbon atoms in the backbone. A composition according to 1. ピリチオン塩が、被覆粒子の重量に基づき、約10%〜約99%の重量%で前記被覆粒子内に存在する、請求項1に記載の組成物。   The composition of claim 1, wherein the pyrithione salt is present in the coated particles in a weight percent of about 10% to about 99%, based on the weight of the coated particles. 親油性剤が、被覆粒子の重量に基づき、約0.01%〜約90%の重量%で前記被覆粒子内に存在する、請求項1に記載の組成物。   The composition of claim 1, wherein a lipophilic agent is present in the coated particles at a weight percent of about 0.01% to about 90%, based on the weight of the coated particles. 被覆粒子が、親油性剤によりその表面が個々に完全に被覆されている、請求項1に記載の組成物。   The composition according to claim 1, wherein the coated particles are individually and completely coated with a lipophilic agent. 被覆粒子が、10〜100Åの厚さを有する被覆を含む、請求項1に記載の組成物。   The composition according to claim 1, wherein the coated particles comprise a coating having a thickness of 10 to 100 mm. 親油性剤が、ラノリン油、魚油、動物油、ココナッツ油、パーム油、バター脂肪、大豆油、ひまわり油、綿実油、コーン油、及びそれらの組合せからなる群から選択されている、請求項1に記載の組成物。   The lipophilic agent is selected from the group consisting of lanolin oil, fish oil, animal oil, coconut oil, palm oil, butter fat, soybean oil, sunflower oil, cottonseed oil, corn oil, and combinations thereof. Composition. 親油性剤がパーム油である、請求項9に記載の組成物。   The composition according to claim 9, wherein the lipophilic agent is palm oil. 更に水又は有機溶媒を含み、但し親油性剤が前記有機溶媒に不溶性であるものとする、請求項1に記載の組成物。   The composition according to claim 1, further comprising water or an organic solvent, wherein the lipophilic agent is insoluble in the organic solvent. 親油性剤がパーム油である、請求項11に記載の組成物。   The composition according to claim 11, wherein the lipophilic agent is palm oil. 更に水又は有機溶媒を含み、但し親油性剤が前記有機溶媒に可溶性であるものとする、請求項1に記載の組成物。   The composition according to claim 1, further comprising water or an organic solvent, wherein the lipophilic agent is soluble in the organic solvent. 前記有機溶媒が、メタノール、エタノール、アセトン、エーテル、ハロゲン化炭化水素、及び芳香族溶媒からなる群から選択されている、請求項13に記載の組成物。   14. The composition of claim 13, wherein the organic solvent is selected from the group consisting of methanol, ethanol, acetone, ether, halogenated hydrocarbons, and aromatic solvents. 局所的キャリヤー、及び一価及び多価ピリチオン塩、及びそれらの組合せからなる群から選択されたピリチオン塩の、親油性剤で部分的又は完全に被覆された被覆粒子を含む、人のケアー組成物。   A human care composition comprising a topical carrier and coated particles of a pyrithione salt selected from the group consisting of mono- and polyvalent pyrithione salts, and combinations thereof, partially or fully coated with a lipophilic agent . 被覆粒子のメジアン粒径が、約0.1〜約50μmである、請求項15に記載の人のケアー組成物。   The human care composition of claim 15, wherein the coated particles have a median particle size of about 0.1 to about 50 μm. ピリチオンの金属塩が、ブロック、板状子、球、棒、針、及びそれらの組合せからなる群から選択された形態で組成物中に存在する、請求項15に記載の人のケアー組成物。   16. The human care composition of claim 15, wherein the metal salt of pyrithione is present in the composition in a form selected from the group consisting of blocks, platelets, spheres, bars, needles, and combinations thereof. 局所的キャリヤーが、水、有機溶媒、又はそれらの組合せを含むシャンプーである、請求項15に記載の人のケアー組成物。   16. A human care composition according to claim 15, wherein the topical carrier is a shampoo comprising water, an organic solvent, or a combination thereof. 有機溶媒が、エタノール、プロパノール、イソプロパノール、グリセリン、及びそれらの組合せからなる群から選択されている、請求項18に記載の人のケアー組成物。   19. The human care composition of claim 18, wherein the organic solvent is selected from the group consisting of ethanol, propanol, isopropanol, glycerin, and combinations thereof. 固体亜鉛ピリチオン粒子で、その外側表面上に固体パーム油被覆を有する固体亜鉛ピリチオン粒子の水性分散物を製造する方法において、
(a) 固体亜鉛ピリチオン粒子の水性分散物を、約50℃〜約80℃の上昇させた温度へ加熱し、高温水性分散物を与える工程、
(b) 固体パーム油を、約50℃〜約80℃の上昇させた温度へ加熱し、液体パーム油を与え、そして
(c) 前記液体パーム油と、前記高温水性分散物とを混合して混合物を与え、前記混合物を冷却して前記固体パーム油の被覆を有する固体亜鉛ピリチオン粒子の水性分散物を与える工程、
を含む、上記製造方法。
In a method of producing an aqueous dispersion of solid zinc pyrithione particles having solid palm oil coating on its outer surface with solid zinc pyrithione particles.
(A) heating an aqueous dispersion of solid zinc pyrithione particles to an elevated temperature of about 50 ° C. to about 80 ° C. to provide a high temperature aqueous dispersion;
(B) heating solid palm oil to an elevated temperature of about 50 ° C. to about 80 ° C. to provide liquid palm oil; and (c) mixing the liquid palm oil with the high temperature aqueous dispersion. Providing a mixture and cooling the mixture to provide an aqueous dispersion of solid zinc pyrithione particles having the solid palm oil coating;
The said manufacturing method containing.
亜鉛ピリチオンの被覆粒子が、分散物の全重量に基づき約40%〜約50%の量で存在する、請求項17に記載の方法に従って製造された、固体パーム油被覆を有する固体亜鉛ピリチオン粒子の水性分散物。   18. Solid zinc pyrithione particles having a solid palm oil coating made according to the method of claim 17, wherein the coated particles of zinc pyrithione are present in an amount of about 40% to about 50% based on the total weight of the dispersion. Aqueous dispersion. 分散物の重量に基づき、約25重量%〜約50重量%のピリチオンの固体粒子、及び水を含む水性抗菌分散濃厚物であって、前記ピリチオン塩の前記固体粒子が、その外側表面に親油性被覆を有する被覆粒子であり、前記被覆粒子が、比較コルネオファンジメトリー生物検定試験で前記ピリチオン塩の未被覆粒子の分散物の抗菌効能と比較して、前記生物検定試験で少なくとも25%の抗菌効能改良を示す、上記水性抗菌分散濃厚物。   An aqueous antimicrobial dispersion concentrate comprising from about 25 wt% to about 50 wt% solid particles of pyrithione and water, based on the weight of the dispersion, wherein the solid particles of the pyrithione salt are lipophilic on the outer surface. Coated particles having a coating, wherein the coated particles have at least 25% antimicrobial activity in the bioassay test compared to the antimicrobial efficacy of the dispersion of uncoated particles of the pyrithione salt in a comparative Corneofundimetric bioassay test. The above aqueous antibacterial dispersion concentrate showing improved efficacy. 局所的キャリヤー、及び人のケアー組成物の全重量に基づき、請求項19に記載の濃厚物を約0.5%〜約5%含む人のケアー組成物であって、同等の量の未被覆ピリチオン塩粒子分散物を含む人のケアー組成物の比較コルネオファンジメトリー生物検定試験での抗菌効能と比較して、前記生物検定試験で少なくとも15%の抗菌効能改良を示す、上記人のケアー組成物。   20. A human care composition comprising from about 0.5% to about 5% of the concentrate according to claim 19 based on the total weight of the topical carrier and the human care composition, wherein an equivalent amount of uncoated Comparison of human care compositions containing pyrithione salt particle dispersions The above human care compositions exhibit at least 15% improvement in antibacterial efficacy in the bioassay test compared to the antibacterial efficacy in the corneophagemetric bioassay test object. 約0.1μ〜約5μの平均粒径を有する固体亜鉛ピリチオン粒子の水性分散物であって、前記粒子が固体パーム油の被覆で被覆されており、前記被覆が被覆粒子の全重量に基づき3重量%〜15重量%を占め、前記被覆粒子が、分散物の全重量に基づき、約40重量%〜約50重量%の量で存在する、上記固体亜鉛ピリチオン粒子水性分散物。   An aqueous dispersion of solid zinc pyrithione particles having an average particle size of about 0.1 μ to about 5 μ, wherein the particles are coated with a coating of solid palm oil, the coating being 3 based on the total weight of the coated particles. The aqueous solid zinc pyrithione particle dispersion as described above, comprising from 15% to 15% by weight, wherein the coated particles are present in an amount of from about 40% to about 50% by weight, based on the total weight of the dispersion. 被覆された亜鉛ピリチオン粒子、及び水又は有機溶媒を含み、然も、前記被覆亜鉛ピリチオン粒子がパーム油で被覆されている、組成物。   A composition comprising coated zinc pyrithione particles and water or an organic solvent, wherein the coated zinc pyrithione particles are coated with palm oil. 被覆材料でピリチオン粒子を被覆する方法において、
(a) 前記ピリチオン粒子を、有機溶媒中に溶解した被覆材料の溶液と接触させる工程、
(b) 前記ピリチオン粒子を、前記有機溶媒中に入れた前記被覆材料と混合する工程、及び
(c) 前記有機溶媒を蒸発して、前記被覆材料で被覆されたピリチオン粒子を与える工程、
を含むピリチオン粒子被覆方法。
In a method of coating pyrithione particles with a coating material,
(A) contacting the pyrithione particles with a solution of a coating material dissolved in an organic solvent;
(B) mixing the pyrithione particles with the coating material in the organic solvent, and (c) evaporating the organic solvent to give pyrithione particles coated with the coating material;
A pyrithione particle coating method comprising:
被覆材料がパーム油である、請求項26に記載の方法。
27. The method of claim 26, wherein the coating material is palm oil.
JP2006534294A 2003-09-30 2004-09-29 Coated metal pyrithione particles for treating microorganisms Active JP4664919B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50744603P 2003-09-30 2003-09-30
US10/952,337 US8980235B2 (en) 2003-09-30 2004-09-28 Coated metal pyrithione particles for treatment of microorganisms
PCT/US2004/032943 WO2005032489A2 (en) 2003-09-30 2004-09-29 Coated metal pyrithione particles for treatment of microorganisms

Publications (2)

Publication Number Publication Date
JP2007508309A true JP2007508309A (en) 2007-04-05
JP4664919B2 JP4664919B2 (en) 2011-04-06

Family

ID=34426008

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006534294A Active JP4664919B2 (en) 2003-09-30 2004-09-29 Coated metal pyrithione particles for treating microorganisms

Country Status (10)

Country Link
US (1) US8980235B2 (en)
EP (1) EP1675572B1 (en)
JP (1) JP4664919B2 (en)
KR (1) KR101106025B1 (en)
CN (1) CN100512876C (en)
AT (1) ATE518524T1 (en)
BR (1) BRPI0414768B1 (en)
ES (1) ES2369853T3 (en)
NO (1) NO20061917L (en)
WO (1) WO2005032489A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016523232A (en) * 2013-06-04 2016-08-08 ビョーメ バイオサイエンシズ ピーブイティー.リミテッド Coated particles and compositions containing same

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2536389A2 (en) * 2010-02-16 2012-12-26 The Procter & Gamble Company Method for providing maximum malodor and irritation control
US9480627B2 (en) * 2010-09-15 2016-11-01 Steven D. Jensen Long term bacteriostatic compounds and their use in restorative dental materials
US8685908B2 (en) 2011-02-28 2014-04-01 The Procter & Gamble Company Bar soap comprising pyrithione sources
JP5694551B2 (en) * 2011-02-28 2015-04-01 ザ ジレット カンパニー Razor with molded shaving aid composition containing pyrithione source
MX2014001896A (en) 2011-08-15 2014-05-27 Procter & Gamble Personal care methods.
MX2014001895A (en) * 2011-08-15 2014-05-27 Procter & Gamble Personal care compositions having dried zinc pyrithione-polymer aggregates.
BR112014002758A2 (en) * 2011-08-15 2017-02-21 Procter & Gamble zinc pyrithione containing personal care compositions
CN104105472A (en) 2011-12-20 2014-10-15 维奥姆生物科学有限公司 Topical oil composition for the treatment of fungal infections
CN104271727A (en) 2012-05-11 2015-01-07 宝洁公司 Personal cleansing compositions comprising zinc pyrithione
WO2014169464A1 (en) 2013-04-18 2014-10-23 The Procter & Gamble Company Personal care compositions containing zinc pyrithione and zinc-phosphonate complex
MX2015012163A (en) 2013-03-14 2015-11-25 Procter & Gamble Bar soap compositions containing zinc pyrithione and a zinc-pyridine oxide complex.
MX2016009898A (en) 2014-01-29 2017-01-23 Vyome Biosciences Pvt Ltd Treatments for resistant acne.
US10201481B2 (en) 2014-03-07 2019-02-12 The Procter & Gamble Company Personal care compositions and methods of making same
US9273192B1 (en) * 2014-11-06 2016-03-01 George Reck Method of preventing microbial growth on water treatment dispersant
EP3291790A1 (en) 2015-05-06 2018-03-14 The Procter and Gamble Company Methods of cosmetically treating skin conditions with a cosmetic personal cleansing composition
EP4127645A1 (en) 2020-03-24 2023-02-08 The Procter & Gamble Company Methods for testing skin samples

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0348604A (en) * 1989-07-12 1991-03-01 L'oreal Sa Aqueous gel cosmetic composition containing sphiloid which is non hydrophilic and a lipoid substance in suspension state
JPH10245409A (en) * 1997-03-03 1998-09-14 Amcol Internatl Corp Oil-and water-absorptive polymer, and its production
JPH11509220A (en) * 1995-07-14 1999-08-17 ユニリーバー・ナームローゼ・ベンノートシヤープ Antimicrobial hair treatment composition
JP2002173410A (en) * 2000-12-06 2002-06-21 Taiki:Kk Fine resin particle for cosmetic
WO2003007900A2 (en) * 2001-07-18 2003-01-30 Unilever Plc Skin treatment
JP2004512349A (en) * 2000-10-30 2004-04-22 ユニリーバー・ナームローゼ・ベンノートシヤープ Shear gel composition
JP2005504812A (en) * 2001-09-28 2005-02-17 アーチ ケミカルズ,インコーポレイテッド Dust-free copper pyrithione dispersion

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87416A1 (en) 1988-12-29 1990-07-10 Cird MICROGRANULES LOADED WITH AN ACTIVE SUBSTANCE, ESSENTIALLY CONSISTING OF A TRIGLYCERIDE OF SATURATED FATTY ACIDS AND THEIR TOPICAL USE IN THE THERAPEUTIC FIELD
US4997641A (en) * 1990-04-09 1991-03-05 Colgate-Palmolive Company Hair conditioning shampoo containing C6 -C10 alkyl sulfate or alkyl alkoxy sulfate
US5674504A (en) 1989-07-12 1997-10-07 L'oreal Cosmetic composition in the form of an aqueous gel containing in suspension spheroids of a non-hydrophilic, lipoidal substance
US5104645A (en) * 1990-02-02 1992-04-14 The Proctor & Gamble Company Antidandruff shampoo compositions
US5393519A (en) * 1992-03-27 1995-02-28 Helene Curtis, Inc. Shampoo compositions
KR19980702385A (en) * 1995-02-21 1998-07-15 찡이앙 알렉스 헤 Imidazolidinone derivatives as corrosion inhibitors
US5968528A (en) * 1997-05-23 1999-10-19 The Procter & Gamble Company Skin care compositions
GB9808310D0 (en) * 1998-04-20 1998-06-17 Unilever Plc Shampoo compositions
US7942958B1 (en) * 1998-07-22 2011-05-17 Arch Chemicals, Inc. Composite biocidal particles
CN1159965C (en) 1999-03-17 2004-08-04 株式会社Api Coated bis (2-pyridinetiol 1-oxide) copper salt
CA2309373A1 (en) 1999-05-27 2000-11-27 Johnson & Johnson Consumer Companies, Inc. Novel topical formulations
US6406745B1 (en) * 1999-06-07 2002-06-18 Nanosphere, Inc. Methods for coating particles and particles produced thereby
US7026308B1 (en) * 1999-06-25 2006-04-11 The Procter & Gamble Company Topical anti-microbial compositions
US6491953B1 (en) * 2000-01-07 2002-12-10 Amcol International Corporation Controlled release compositions and method
US6635702B1 (en) * 2000-04-11 2003-10-21 Noveon Ip Holdings Corp. Stable aqueous surfactant compositions
JP3928337B2 (en) 2000-07-04 2007-06-13 穣 滝澤 Method for producing flavored butyric acid bacteria powder and culture solution of flavored butyric acid bacteria
MXPA04003009A (en) 2001-10-03 2004-07-15 Procter & Gamble Shampoo containing a cationic polymer and particles.

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0348604A (en) * 1989-07-12 1991-03-01 L'oreal Sa Aqueous gel cosmetic composition containing sphiloid which is non hydrophilic and a lipoid substance in suspension state
JPH11509220A (en) * 1995-07-14 1999-08-17 ユニリーバー・ナームローゼ・ベンノートシヤープ Antimicrobial hair treatment composition
JPH10245409A (en) * 1997-03-03 1998-09-14 Amcol Internatl Corp Oil-and water-absorptive polymer, and its production
JP2004512349A (en) * 2000-10-30 2004-04-22 ユニリーバー・ナームローゼ・ベンノートシヤープ Shear gel composition
JP2002173410A (en) * 2000-12-06 2002-06-21 Taiki:Kk Fine resin particle for cosmetic
WO2003007900A2 (en) * 2001-07-18 2003-01-30 Unilever Plc Skin treatment
JP2005504812A (en) * 2001-09-28 2005-02-17 アーチ ケミカルズ,インコーポレイテッド Dust-free copper pyrithione dispersion

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016523232A (en) * 2013-06-04 2016-08-08 ビョーメ バイオサイエンシズ ピーブイティー.リミテッド Coated particles and compositions containing same

Also Published As

Publication number Publication date
BRPI0414768B1 (en) 2015-09-08
BRPI0414768A (en) 2006-11-21
ES2369853T3 (en) 2011-12-07
KR101106025B1 (en) 2012-01-17
CN1859899A (en) 2006-11-08
JP4664919B2 (en) 2011-04-06
ATE518524T1 (en) 2011-08-15
EP1675572B1 (en) 2011-08-03
US20050118276A1 (en) 2005-06-02
US8980235B2 (en) 2015-03-17
KR20060109444A (en) 2006-10-20
CN100512876C (en) 2009-07-15
WO2005032489A2 (en) 2005-04-14
EP1675572A4 (en) 2009-12-23
WO2005032489A3 (en) 2005-11-24
NO20061917L (en) 2006-06-15
EP1675572A2 (en) 2006-07-05

Similar Documents

Publication Publication Date Title
JP4664919B2 (en) Coated metal pyrithione particles for treating microorganisms
CA2285285C (en) Method for making a product adhere to a surface
JP5059760B2 (en) Topical formulations including outer skins containing sporopolenin, products, and methods of use thereof
US20210315784A1 (en) Structured Rheological Solid Compositions
KR100280898B1 (en) Novel salicylic acid derivatives and their use in a cosmetic and/or dermatological composition
JP7004387B2 (en) Biocellulose fine fiber aqueous dispersion network composition
CN110613632A (en) Pet washing and caring composition rich in hyaluronic acid or salt thereof and preparation method thereof
JP2021514970A (en) Compositions and methods of use to provide skin care effects
JP5616008B2 (en) Use of purerin for hair follicle treatment
CA2356840A1 (en) Compositions and methods of using the same
CN107550761A (en) A kind of make-up remover containing chitosan and preparation method thereof
EP1408924A1 (en) Stabilized ascorbic acid, composition, and method of use
KR101446706B1 (en) Composition for skin rejuvenation comprising FGF
JP4696107B2 (en) Use of extracts of plants belonging to the genus Buchholsia in cosmetics and pharmaceuticals
JP3051119B1 (en) Disinfectant composition
TWI759283B (en) Composition containing biocellulose microfibril network water dispersions, compositions, and uses thereof
JP2016104713A (en) Antiperspirant or deodorant agent
US20230301881A1 (en) Personal care compositions with antimicrobial, hydrodynamic, and antioxidant nanoparticles
JP2003040725A (en) Oil gel cosmetic
JP7376064B2 (en) Carbonylation inhibitor of epidermal proteins
EP1155685B1 (en) Composition containing manganese
JPH07304647A (en) Composition for massage
JPS58134009A (en) Skin treatment composition
JP2023098871A (en) Deodorant composition
JPS6172708A (en) Humidity preserving cream for clean room

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070817

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100622

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100921

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100929

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100929

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101026

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101116

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20101217

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110107

R150 Certificate of patent or registration of utility model

Ref document number: 4664919

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140114

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250